Italian tax authorities investigate Pfizer profits -sources

Published 10/27/2022, 06:33 AM
Updated 10/27/2022, 06:36 AM
© Reuters. FILE PHOTO: Doses of Pfizer coronavirus disease (COVID-19) vaccines are seen in a mass vaccination site supported by the federal government at the Miami Dade College North Campus in Miami, Florida, U.S., March 10, 2021. REUTERS/Marco Bello
PFE
-

MILAN (Reuters) - Italy's tax authorities are investigating profits reported by Pfizer Inc (NYSE:PFE)'s local unit Pfizer Italia srl, two sources with knowledge of the matter told Reuters on Thursday.

"Italian tax authorities regularly monitor and investigate taxes paid by Pfizer and Pfizer cooperates with these controls and investigations," the U.S. pharmaceuticals company said.

"Pfizer complies with the laws and obligations to the Italian tax authorities", it added in an emailed statement.

Italy's finance police and revenue agency declined comment.

© Reuters. FILE PHOTO: Doses of Pfizer coronavirus disease (COVID-19) vaccines are seen in a mass vaccination site supported by the federal government at the Miami Dade College North Campus in Miami, Florida, U.S., March 10, 2021. REUTERS/Marco Bello

The checks being carried out by the finance police in Rome are an administrative audit not a criminal probe and Pfizer has not yet been informed of the findings, the two sources said.

At the end of the process the police must under Italian law report the outcome to the company involved and the state revenue agency, which then draws up a so-called deed of acceptance of the assessment and the payment of any amount deemed due.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.